Recent Analyst Forecasts and Stock Ratings
Neurocrine Biosciences, Inc. FAQ's
Neurocrine Biosciences, Inc. has been rated by research analysts at Stifel Nicolaus, RBC Capital, Truist Financial, UBS, Mizuho Securities, BMO Capital in the past 90 days.